Clinical Trials Logo

Muscle Injury clinical trials

View clinical trials related to Muscle Injury.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06167850 Completed - Muscle Injury Clinical Trials

Effect of the Copenhagen Plank on Aductional Strenght and Vertical Jump in Female Football Players

ECA
Start date: January 9, 2023
Phase: N/A
Study type: Interventional

There is enough evidence to know the high incidence of groin injuries in soccer. Despite this, there is not enough about these in women's football. The researchers perform the Copenhagen plank to obtain an improvement in the improvement of adductor strength and the reduction of groin injuries

NCT ID: NCT05988476 Completed - Muscle Injury Clinical Trials

Investıgatıon of The Effıciency of Pulsed Electromagnetıc Field Therapy and Stretching Exercises

Start date: September 5, 2022
Phase: N/A
Study type: Interventional

In this study, a total of 69 Wistar Albino rats were used, five of which were in the preliminary study. The preliminary study was planned to determine the ideal PEMF treatment time. In the study, animals were divided into 5 groups (Control, INJ, INJ+Exercise, INJ+PEMF, INJ+Exercise+PEMF). Experimental animals were sacrificed on the 7th and 14th days to see the effects of the treatments. At the end of the experiment, genetic, histopathological, and immunohistochemical evaluations were made in the muscle tissue.

NCT ID: NCT05827484 Completed - Sport Injury Clinical Trials

The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries

Start date: October 10, 2016
Phase: Phase 4
Study type: Interventional

The aim of this comparative study is to determine whether or not LOSARTAN with its anti-fibrotic action has an added effect when administrated with platelet rich plasma injection on skeletal muscle healing and on decreasing the fibrous scar after muscle injuries in comparison with the sole administration of platelet rich plasma.

NCT ID: NCT05367648 Completed - Muscle Injury Clinical Trials

Effects of Protein Hydrolysate Supplement on Systemic Muscle Function Markers Following Resistance Type Exercise in Male Subjects

Start date: September 24, 2020
Phase: N/A
Study type: Interventional

The effect of exercise on serum concentrations of creatine kinase (CK) and subsequent use of protein hydrolysate supplementation, Elio, to influence the expression of CK following resistance type exercise in male subjects. A two subject trial of Elio administered 3 grams per day in assessing its effects on post-exercise increases in markers associated with muscle injury and exertion

NCT ID: NCT05361928 Completed - Muscle Injury Clinical Trials

IS ElastomEtry Useful in Muscle Lesion evaluaTion-REPROducibility Study

ISEULT-Repro
Start date: January 10, 2021
Phase:
Study type: Observational

Our objective is to evaluate the inter and intra observer reproducibility of the measure of elasticity using Acoustic Radiation Force Impulse (ARFI) ultrasonography of mucles of patients with and without hamstring injury. 76 patients will be evaluated cross sectionally twice by two ultrasonographists.

NCT ID: NCT05254470 Completed - Back Pain Clinical Trials

Real-World Experience of Patients Treated for Musculoskeletal Injuries With SAM in Routine Care

Start date: September 1, 2020
Phase:
Study type: Observational

The purpose of this study is to evaluate continuous ultrasound treatment with diclofenac coupling patch during routine care of musculoskeletal injuries which failed conservative treatment to better understand clinical utilization of the treatment on types of injuries, how the treatment helps patients (pain, function and quality of life), and information on healthcare provider ordering the therapy and general workflow. Low-intensity continuous ultrasound (LICUS) is a bio regenerative technology used when normal rehabilitation is insufficient, applied with a wearable device (SAM, Zetroz Systems LLC) for daily use. The treatment provides long-duration ultrasound for approximately four hours. The objective of this study is to examine the real-world outcome data on symptoms improvement and return to function using SAM during routine care.

NCT ID: NCT05159375 Completed - Muscle Injury Clinical Trials

Effects of Protein Hydrolysate Supplementation Influencing Strength Recovery and Expression of Muscle Damage Markers Post-exercise

Start date: August 6, 2021
Phase: N/A
Study type: Interventional

A randomised placebo controlled, double-blind, 30 Volunteer trial of Elio™ administered 2.4 grams per day in assessing its effects on post-exercise strength recovery and increases in markers associated with muscle injury and exertion.

NCT ID: NCT04874662 Completed - Muscle Injury Clinical Trials

Nicotinamide (NAM) and Pyridoxine (Vitamin B6) on Muscle Regeneration ("Satellite-01 Study").

Start date: May 3, 2021
Phase: N/A
Study type: Interventional

Assessment of safety and efficacy of NAM/B6 oral administration on the amplification and commitment of satellite cells after a muscle injury

NCT ID: NCT04742244 Completed - Muscle Soreness Clinical Trials

Lemon Verbena Extract Oxidative Stress and Muscle Damage

Start date: May 28, 2020
Phase: N/A
Study type: Interventional

In the present study, investigators investigated whether supplementation with lemon verbena extract (LVE) could improve muscle damage and biochemical indicators after exhaustive exercise challenge. Based on maximum jump heights, 60 subjects (30 males and 30 females) were equally divided into a placebo group (0 mg/human/day) and an LVE supplement group (400 mg/human/day), with gender-equal distribution. All subjects started supplementation 10 days before exhaustive exercise and continued it until all tests were completed. Before the intervention, after the exhaustive exercise, and on the following 3 days, the participants underwent 12-minute Cooper running/walking; blood collection; assessments of pain, muscle stiffness, maximum jump heights, and isometric maximum muscle strength; and anaerobic strength tests.

NCT ID: NCT04586712 Completed - Recovery Clinical Trials

Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle Injury

Start date: March 1, 2021
Phase: Phase 2
Study type: Interventional

The study aims to determine the efficacy of a controlled short-term trial of CBD ingestion for reducing symptomatic response and facilitating recovery following induced muscle injury. A double-blind, randomized, three-arm study design will be used and participants will be randomly assigned to either a high dose (n=15), low dose (n=15), or vehicle control group (n=15). The clinical outcomes include measures of muscular pain and disability along with measures of pain-related fear and anxiety.